特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
907042

世界の細胞生存性アッセイ市場:成長、動向、予測

Cell Viability Assays Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 115 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
世界の細胞生存性アッセイ市場:成長、動向、予測
出版日: 2020年08月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 115 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の細胞生存性アッセイ市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
  • 市場阻害因子
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 消耗品
      • 試薬
      • アッセイキット
      • その他
    • 計器
      • 自動細胞カウンター
      • フローサイトメトリー
      • 分光光度計
      • その他
  • 用途別
    • 創薬・開発
    • 幹細胞研究
    • 臨床、診断
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合環境

  • 企業プロファイル
    • Abcam Plc
    • Becton Dickinson & Company
    • Bio-Rad Laboratories
    • Biotek Instruments
    • Creative Bioarray
    • GE Healthcare
    • Merck KGaA
    • Perkin Elmer
    • Promega Corporation
    • Thermo Fischer Scientific Inc.

第7章 市場の機会と将来動向

目次
Product Code: 65547

The Cell Viability Assays Market is expected to register a CAGR of 7.7% during the forecast period. The major factors for the growth of the cell viability assays market include the growing burden of chronic and infectious diseases, rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics.

Furthermore, according to the World Health Organization (WHO), chronic diseases are expected to increase by 57% by 2020. Furthermore, as per the Globocan Database, the number of new cases was estimated to increase from 18.1 million to 29.4 million, between 2018 and 2040.

In the emerging markets, cancer and heart diseases are becoming the main causes of death, as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. Thus, the growing burden of chronic diseases is expected to boost cell-based research, resulting in the high growth of the market.

Key Market Trends

Stem Cell Research Segment is Estimated to Register the Fastest Growth Over the Forecast Period

The stem cell research segment is estimated to register the fastest growth, owing to the rising R&D activities and funding from various organizations. According to the National Institutes of Health (NIH), an estimated USD 1,748 million was granted for stem cell research in 2018.

The technological advancements play a significant role in the future with multiple experiments in pluripotent stem cells being the center for exciting growth. For instance, in September 2018, researchers from China and the United States have developed a novel bio-ink that can efficiently bioprint, culture, and expand the human induced pluripotent stem cells and this type of innovation is likely to fuel the market growth in future years.

Thus, considering all the aforementioned factors, the market is expected to witness high growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America holds a major share for the cell viability assays market, and it is expected to witness a similar trend over the forecast period, without significant fluctuations. The region is dominating the market, due to various factors, like the increasing incidences of chronic diseases, rise in investment initiatives by governments, and high-quality infrastructure for clinical and laboratory research.

According to the estimates of the American Cancer Society, in the United States, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths due to cancer in 2018. In addition, it is estimated that in 2020 there will be about 1.8 million new cancer cases diagnosed and approximately 606,520 cancer deaths in the United States.​

Furthermore, in the United States, there is a rise in the funding for cell-based research, which is expected to propel the overall growth of the cell viability assay market, over the forecast period.

Competitive Landscape

The cell viability assays market is fragmented competitive owing to the presence of various small and large market players. Some of the market players are Abcam PLC, Becton Dickinson & Company, Bio-Rad Laboratories, Biotek Instruments, Creative Bioarray, GE Healthcare, Merck KGaA, Perkin Elmer, Promega Corporation, and Thermo Fischer Scientific Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic and Infectious Diseases
    • 4.2.2 Rising Demand for Cell-based Assays in Research
    • 4.2.3 Increasing Focus on the Development of Cell-based Therapeutics
  • 4.3 Market Restraints
    • 4.3.1 Limitations of the Assays
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product
    • 5.1.1 Consumables
      • 5.1.1.1 Reagents
      • 5.1.1.2 Assay Kits
      • 5.1.1.3 Other Consumables
    • 5.1.2 Instruments
      • 5.1.2.1 Automated Cell Counters
      • 5.1.2.2 Flow Cytometers
      • 5.1.2.3 Spectrophotometers
      • 5.1.2.4 Other Instruments
  • 5.2 Application
    • 5.2.1 Drug Discovery and Development
    • 5.2.2 Stem Cell Research
    • 5.2.3 Clinical and Diagnostic Applications
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abcam PLC
    • 6.1.2 Becton Dickinson & Company
    • 6.1.3 Bio-Rad Laboratories
    • 6.1.4 Biotek Instruments
    • 6.1.5 Creative Bioarray
    • 6.1.6 GE Healthcare
    • 6.1.7 Merck KGaA
    • 6.1.8 Perkin Elmer
    • 6.1.9 Promega Corporation
    • 6.1.10 Thermo Fischer Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.